Carmen Blanco Aparicio

Title: Carmen Blanco Aparicio: Innovator in Kinase Inhibitor Research

Introduction

Carmen Blanco Aparicio is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 3 patents to her name, her work focuses on innovative compounds that have the potential to treat various diseases, including cancer.

Latest Patents

One of her latest patents is titled "Macrocyclic compounds as protein kinase inhibitors." This invention provides compounds of formula I, wherein R1, R, R, R, X, Y, Z, and ring A/B have specific meanings as described. These compounds are useful in treating diseases where inhibition of a protein or lipid kinase, such as PI3-K, particularly class I PI3K, PIM family kinase, and/or mTOR, is desired. The invention also includes combinations containing such compounds.

Another notable patent is "Tricyclic compounds for use as kinase inhibitors." This patent describes compounds of formula (I), where R, R, R, and R have meanings provided in the description. These compounds are also useful in treating diseases requiring the inhibition of a protein or lipid kinase, particularly in the context of cancer or proliferative diseases. The patent further includes combinations comprising these compounds.

Career Highlights

Carmen has worked with esteemed organizations such as Fundación Centro Nacional de Investigaciones Oncológicas Carlos III and Centro Nacional de Investigaciones Oncológicas (CNIO). Her research has significantly advanced the understanding and treatment of cancer through innovative therapeutic approaches.

Collaborations

Throughout her career, Carmen has collaborated with notable colleagues, including Joaquín Pastor Fernández and Antonio Rodríguez Hergueta. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Carmen Blanco Aparicio is a trailblazer in the field of kinase inhibitor research, with a focus on developing novel compounds for cancer treatment. Her contributions through her patents and collaborations continue to impact the scientific community positively.